Latest Updates

New treatments for advanced prostate cancer

QUT’s TRI-based Dr Lisa Philp is combining her knowledge of hormones and metabolism to develop a new treatment for late stage prostate cancer.

Read more

$10 Million Investment for Melanoma Screening Program

World-first 3D imaging for melanoma detection launched at TRI.

Read more

Jian Zhou Medal Awarded to TRI Scientist

The Australian Academy of Health and Medical Sciences’ has awarded its 2021 Jian Zhou Medal to Professor Di Yu.

Read more

An Australian-first initiative of 'bench to bedside' medical research

The Translational Research Institute (TRI) is a unique, Australian-first initiative of ‘bench to bedside’ medical research. TRI combines clinical and translational research to advance progress from laboratory discovery to application in the community.

The work conducted at TRI is translational research, a research process which involves teams of patients, clinicians and researchers working together to solve health challenges faster. The work is driven by the needs of patients, a question formed by a clinician and a solution sought by a scientist.

Find out more

What is Translational Research?

Also known as 'bench-to-bedside' research, it is a type of medical research that focusses on 'translating' basic science discoveries from the laboratory into the clinic.

The aim is to improve how we detect, diagnose and treat health conditions, and improve health outcomes for patients.

At TRI, we work to develop new treatments and diagnostics for conditions ranging from various cancers to autoimmune diseases, and translate these discoveries into improved healthcare.

Find out more

What's On


ASSC Genetics Summit 21 March 2022

The Australian Skin and Skin Cancer Research Centre (ASSC) is hosting the Genetics Summit

9:30 am6:00 pm